Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
576
-
Total 13F shares, excl. options
-
25.1M
-
Shares change
-
-250K
-
Total reported value, excl. options
-
$8.38B
-
Value change
-
-$157M
-
Put/Call ratio
-
4.84
-
Number of buys
-
307
-
Number of sells
-
-301
-
Price
-
$333.80
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q3 2024
700 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q3 2024.
Medpace Holdings, Inc. - Common Stock (MEDP) has 576 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.1M shares
of 30.9M outstanding shares and own 81.26% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.69M shares), VANGUARD GROUP INC (2.55M shares), WASATCH ADVISORS LP (909K shares), STATE STREET CORP (753K shares), GEODE CAPITAL MANAGEMENT, LLC (628K shares), Invesco Ltd. (566K shares), RIVERBRIDGE PARTNERS LLC (552K shares), TD Asset Management Inc (503K shares), BESSEMER GROUP INC (501K shares), and RENAISSANCE TECHNOLOGIES LLC (492K shares).
This table shows the top 576 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.